PROMNIX 0.4

البلد: إسرائيل

اللغة: الإنجليزية

المصدر: Ministry of Health

العنصر النشط:

TAMSULOSIN HYDROCHLORIDE

متاح من:

TARO INTERNATIONAL LTD, ISRAEL

ATC رمز:

G04CA02

الشكل الصيدلاني:

MODIFIED RELEASE CAPSULES HARD

تركيب:

TAMSULOSIN HYDROCHLORIDE 0.4 MG

طريقة التعاطي:

PER OS

نوع الوصفة الطبية :

Required

المصنعة من قبل:

SYNTHON B.V., NETHERLANDS

المجموعة العلاجية:

TAMSULOSIN

المجال العلاجي:

TAMSULOSIN

الخصائص العلاجية:

Treatment of functional symptoms of benign prostatic hyperplasia (BPH).

تاريخ الترخيص:

2022-07-31

نشرة المعلومات

Page 1 of 4
PATIENT LEAFLET IN ACCORDANCE WITH THE PHARMACISTS' REGULATIONS
(PREPARATIONS) - 1986
This medicine is dispensed with a doctor’s prescription only
PROMNIX
® 0.4
MODIFIED RELEASE CAPSULES
ACTIVE INGREDIENT AND ITS QUANTITY:
tamsulosin hydrochloride 0.4 mg
Inactive ingredients and allergens - see section 6 ‘Additional
information”.
READ THE ENTIRE LEAFLET CAREFULLY BEFORE YOU START USING THIS
MEDICINE. This leaflet
contains concise information about this medicine. If you have any
further questions, consult
your doctor or pharmacist.
This medicine has been prescribed to treat your illness. Do not pass
it on to others. It may
harm them even if it seems to you that their illness is similar to
yours.
The medicine is not intended for children and adolescents below the
age of 18.
1.
WHAT IS THIS MEDICINE INTENDED FOR?
The medicine is intended for the treatment of functional disorders
caused by benign prostatic
hyperplasia (BPH).
THERAPEUTIC GROUP: selective alpha 1A,1D adrenoreceptor antagonist.
2.
BEFORE USING THIS MEDICINE
DO NOT USE THIS MEDICINE IF:
•
you are sensitive (allergic) to tamsulosin or to any of the other
ingredients
contained in the medicine (see section 6). Hypersensitivity may be
manifested as
sudden local swelling of the soft tissues of the body (such as throat
or tongue),
difficulty breathing and/or itching and rash (angioedema)
.
•
you are suffering from severe liver failure.
•
you are suffering from dizziness or fainting resulting from a drop in
blood
pressure when changing position (transitioning from a lying to a
sitting or
standing position (orthostatic hypotension)).
SPECIAL WARNINGS ABOUT USING THIS MEDICINE:
•
In rare instances, this medicine can cause fainting. At the first
signs of dizziness or
weakness, the patient should sit or lie down until the condition
resolves.
•
BEFORE USING PROMNIX, TELL YOUR DOCTOR IF:
o
you suffer or have suffered in the past from severe kidney problems.
o
you are about to undergo eye surgery for cataract removal, or if you
suffer
from